Vasilios Karavasilis - Publications

Optimal clinical management of tenosynovial giant cell tumours: a UK perspective.

Journal: Bone & joint open

Published: April 02, 2026

Clinical Presentation and Tumour Burden in Head and Neck Sarcomas: Implications for Early Diagnosis and Referral.

Journal: Cancers

Published: March 08, 2026

Improving head and neck sarcoma care: The impact of a specialized multidisciplinary team approach on diagnosis and patient outcomes.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 06, 2024

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.

Journal: International journal of molecular sciences

Published: June 12, 2023

Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients.

Journal: Expert opinion on pharmacotherapy

Published: September 14, 2022

Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA".

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 15, 2021

Genotyping data of routinely processed matched primary/metastatic tumor samples.

Journal: Data in brief

Published: November 04, 2020

Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.

Journal: Cancers

Published: October 21, 2020

Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastases.

Journal: Human pathology

Published: July 20, 2020

Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.

Journal: Cancer genomics & proteomics

Published: August 01, 2019

Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG).

Journal: ESMO open

Published: April 04, 2019

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Journal: Targeted oncology

Published: November 30, 2018